These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10950333)

  • 1. Outcomes for children with cardiomyopathy awaiting transplantation.
    Nield LE; McCrindle BW; Bohn DJ; West LJ; Coles JG; Freedom RM; Benson LN
    Cardiol Young; 2000 Oct; 10(4):358-66. PubMed ID: 10950333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of children with restrictive cardiomyopathy listed for heart transplant: a multi-institutional study.
    Zangwill SD; Naftel D; L'Ecuyer T; Rosenthal D; Robinson B; Kirklin JK; Stendahl G; Dipchand AI;
    J Heart Lung Transplant; 2009 Dec; 28(12):1335-40. PubMed ID: 19783176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.
    Singh TP; Sleeper LA; Lipshultz S; Cinar A; Canter C; Webber SA; Bernstein D; Pahl E; Alvarez JA; Wilkinson JD; Towbin JA; Colan SD
    Circ Heart Fail; 2009 Nov; 2(6):591-8. PubMed ID: 19919984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.
    Pietra BA; Kantor PF; Bartlett HL; Chin C; Canter CE; Larsen RL; Edens RE; Colan SD; Towbin JA; Lipshultz SE; Kirklin JK; Naftel DC; Hsu DT
    Circulation; 2012 Aug; 126(9):1079-86. PubMed ID: 22800850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?
    Garbern JC; Gauvreau K; Blume ED; Singh TP
    Circ Heart Fail; 2016 Jan; 9(1):e002328. PubMed ID: 26699389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current outcomes in US children with cardiomyopathy listed for heart transplantation.
    Singh TP; Almond CS; Piercey G; Gauvreau K
    Circ Heart Fail; 2012 Sep; 5(5):594-601. PubMed ID: 22899768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
    Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
    Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
    Seferović PM; Polovina M; Bauersachs J; Arad M; Ben Gal T; Lund LH; Felix SB; Arbustini E; Caforio ALP; Farmakis D; Filippatos GS; Gialafos E; Kanjuh V; Krljanac G; Limongelli G; Linhart A; Lyon AR; Maksimović R; Miličić D; Milinković I; Noutsias M; Oto A; Oto Ö; Pavlović SU; Piepoli MF; Ristić AD; Rosano GMC; Seggewiss H; Ašanin M; Seferović JP; Ruschitzka F; Čelutkiene J; Jaarsma T; Mueller C; Moura B; Hill L; Volterrani M; Lopatin Y; Metra M; Backs J; Mullens W; Chioncel O; de Boer RA; Anker S; Rapezzi C; Coats AJS; Tschöpe C
    Eur J Heart Fail; 2019 May; 21(5):553-576. PubMed ID: 30989768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of mitral regurgitation predicts risk of death or cardiac transplantation in children with idiopathic dilated cardiomyopathy.
    Patange A; Thomas R; Ross RD
    Pediatr Cardiol; 2014 Feb; 35(2):232-8. PubMed ID: 23917522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation, management and outcomes of thrombosis for children with cardiomyopathy.
    McCrindle BW; Karamlou T; Wong H; Gangam N; Trivedi KR; Lee KJ; Benson LN
    Can J Cardiol; 2006 Jun; 22(8):685-90. PubMed ID: 16801999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy.
    Kantor PF; Abraham JR; Dipchand AI; Benson LN; Redington AN
    J Am Coll Cardiol; 2010 Mar; 55(13):1377-84. PubMed ID: 20338500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy.
    Etoch SW; Koenig SC; Laureano MA; Cerrito P; Gray LA; Dowling RD
    J Thorac Cardiovasc Surg; 1999 May; 117(5):952-9. PubMed ID: 10220690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of children following a first hospitalization for dilated cardiomyopathy.
    Hollander SA; Bernstein D; Yeh J; Dao D; Sun HY; Rosenthal D
    Circ Heart Fail; 2012 Jul; 5(4):437-43. PubMed ID: 22570362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.
    Foerster SR; Canter CE; Cinar A; Sleeper LA; Webber SA; Pahl E; Kantor PF; Alvarez JA; Colan SD; Jefferies JL; Lamour JM; Margossian R; Messere JE; Rusconi PG; Shaddy RE; Towbin JA; Wilkinson JD; Lipshultz SE
    Circ Heart Fail; 2010 Nov; 3(6):689-97. PubMed ID: 20833772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
    Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac support device, restrictive mitral valve annuloplasty, and optimized medical treatment: a multimodality approach to nonischemic cardiomyopathy.
    Braun J; Ciarka A; Versteegh MI; Delgado V; Boersma E; Verwey HF; Schalij MJ; Bax JJ; Dion RA; van de Veire NR; Klautz RJ
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):e93-100. PubMed ID: 21397275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcomes in children awaiting heart transplantation: an experience from a National Paediatric Heart Transplantation Programme.
    Shi WY; Rouse M; Weintraub RG; Zannino D; Shipp A; d'Udekem Y; Konstantinov IE
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1711-8. PubMed ID: 26802205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
    Lietz K; Miller LW
    J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.